Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day.

Data is taken at the market close – at 4.10pm AEDT.

Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.

 

WINNERS

Scroll or swipe to reveal table. Click headings to sort.

UK-based oil and gas explorer Doriemus (ASX:DOR) rose by 107 per cent off the back of a $3 million capital raising.

Cogstate (ASX:CGS), one of the few ASX stocks fighting Alzheimers, rose after the FDA approved the first ever drug shown to fight Alzheimers head on (as opposed to merely treating symptoms).

The drug is owned by Biogen which is a partner of Cogstate’s parter Eisai. Cogstate says the green light will be good for its own solutions.

In resources, the top winner with news was Dateline Resources (ASX:DTR). The gold junior revealed the results of ore processing trials which could boost gold grades, reduce processing costs and increase potential profits.

 

LOSERS

Scroll or swipe to reveal table. Click headings to sort.

Taruga Minerals (ASX:TAR) declined off the back of an exploration update.